阿奇霉素联合羧甲司坦治疗急性支气管炎的效果分析  

Analysis of Effect of Azithromycin and Carboxymethylcysteine in Treatment of Acute Bronchitis

作　　者：王建场 

机构地区：[1]山东枣庄联创有限责任公司医院内科,山东枣庄277011

出　　处：《中外医疗》2017年第5期102-103,106,共3页China & Foreign Medical Treatment

摘　　要：目的分析在治疗急性支气管炎时应用阿奇霉素联合羧甲司坦的临床效果。方法从该院于2015年8月—2016年8月收治的急性支气管炎患者中方便抽取152例作为研究对象,随机分为实验组与对照组,每组76例。给予对照组患者阿奇霉素进行治疗,实验组患者则在对照组的基础上联合羧甲司坦进行治疗。结果实验组患者治疗的总有效率为92.11%,明显低于对照组患者的72.37%,差异有统计学意义(P<0.05)。实验组患者的症状及阳性体征持续时间、给药治疗时间及不良反应发生率在数值上均明显小于对照组患者,差异有统计学意义(P<0.05)。结论在对急性支气管炎患者进行临床治疗时,应用阿奇霉素联合羧甲司坦能够有效提高治疗效果及效率、缩短症状及阳性体征持续时间、降低不良反应发生率。Objective To analyze the clinical effect of azithromycin and carboxymethylcysteine in treatment of acute bronchitis. Methods Convenient selection 152 cases of patients with acute bronchitis admitted and treated in our hospital from August 2015 to August 2016 were selected as the research objects and randomly divided into two groups with 76 cases in each, the control group were treated with Azithromycin, while the experimental group were treated with carboxymethylcysteine on the basis of the control group Results The total treatment effective rate in the experimental group was obviously lower than that in the control group（92.11% vs 72.37%）, and the difference had statistical significance（P〈0.05）, and the symptom and positive sign duration, administration treatment time and incidence rate of adverse reactions in the experimental group were obviously lower than those in the control group, and the differences had statistical significance（P 0.05）.Conclusion The application of Azithromycin and carboxymethylcysteine in treatment of acute bronchitis can effectively improve the treatment effect and efficacy, shorten the symptom and positive sign duration and reduce the incidence rate of adverse reactions.

关 键 词：阿奇霉素 羧甲司坦 急性支气管炎 

分 类 号：R56[医药卫生—呼吸系统]